Paper Review Records
全部论文审稿周期
24 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
145
天
M-CSF–driven TAM remodelling and actomyosin reactivation underlie BRAFi resistance in melanoma
作者
Pol Sisó; Oscar Maiques; Judith Gracia-Bolívar; Christopher Ríos; Cristina Megino-Luque; Manel Albertí-Valls; Xavier Soria; Marta C. Sallan; Shukri Xalane; Lídia Sánchez-Moral; Yomara Morant; Maria Rosa Sarrias; Joan Verdaguer; Rosa Penin; Josep Maria Piulats; Núria Eritja; Susana Puig; Victoria Sanz-Moreno; Xavier Matias-Guiu; Rosa Maria Martí; Anna Macià展开收起
作者单位
1. Oncologic Pathology Group, Biomedical Research Institute of Lleida – Dr. Pifarré Foundation, IRBLleida (ROR: 03mfyme49)Lleida, Spain; 2. Department of Experimental Medicine, University of Lleida, Lleida, Spain; 3. Cytoskeleton and Cancer Metastasis Group, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK; 4. Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, UK; 5. Department of Medicine, Division of Haematology and Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, USA; 6. Centre of Biomedical Research On Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain; 7. Department of Medicine and Surgery, University of Lleida, Lleida, Spain; 8. Department of Dermatology, Hospital Universitari Arnau de Vilanova de Lleida, Institut de Recerca Biomèdica de Lleida (IRBLleida), University of Lleida, Lleida, Spain; 9. Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, UK; 10. Innate Immunity Group, Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain; 11. Centre for Biomedical Research in Hepatic and Digestive Diseases (CIBERehd), Madrid, Spain; 12. Immunology Unit, Biomedical Research Institute of Lleida – Dr. Pifarré Foundation, IRBLleida (ROR: 03mfyme49), Lleida, Spain; 13. CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain; 14. Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain; 15. Department of Medical Oncology, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain; 16. Melanoma Unit, Dermatology Department, University of Barcelona, Hospital Clínic & IDIBAPS (Institut d’Investigacions Biomèdiques August Pi I Sunyer), Barcelona, Spain; 17. Centro Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain; 18. Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, UK; 19. Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova de Lleida, Institut de Recerca Biomèdica de Lleida (IRBLleida), University of Lleida, Lleida, Spain展开收起
169
天
Tetrandrine stabilizes NCOA4 to promote ferritinophagy-mediated ferroptosis and enhance antitumor immunity in NSCLC
作者
Cong Xu; Xiaoyue Du; Zihan Xu; Zebo Jiang; Miaolin Zhu; Yulan Gu; Chen Peng; Shiying Zhu; Xin Wang; Bing Feng; Bowen Hu; Rujia Si; Qibiao Wu; Guoren Zhou; Feng Jiang; Shaodi Wen; Bo Shen展开收起
作者单位
1. Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Jiangsu, Nanjing, China; 2. Affiliated Zhuhai Hospital, Zhuhai Hospital of Integrated Traditional Chinese & Western Medicine, Southern Medical University, Zhuhai, China; 3. Oncology Department of Changshu Second Hospital, Changshu, China; 4. State Key Laboratory of Quality Research in Chinese Medicines and Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macau SAR; 5. Department of Oncology, Huaian People Hospital of Hongze District, Huaian, China; 6. DongTai People’s Hospital, Dongtai, China展开收起
103
天
Protein acylation in cancer: from regulatory networks to precision therapeutics
作者
Zhixi Wei; Chi Ma; Jiajun Gao; Xinyi Zhang; Yiping Xu; Daoxin Ma; Wancheng Liu; Xiangling Xing展开收起
作者单位
1. Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, PR China; 2. Department of Hematology, Qilu Hospital of Shandong University, Jinan, PR China; 3. Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan, P.R. China展开收起
140
天
Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma
作者
Katie Stoker; Roman Laddach; Lucy Booth; Silvia Crescioli; Oscar Maiques; Rebecca Adams; Jitesh Chauhan; Alexander Stewart; Dinethri Patel; Amanda Fitzpatrick; Yin Wu; Jenny L. C. Geh; Omar Salem; Alastair D MacKenzie Ross; Hawys Lloyd-Hughes; Sean Whittaker; Joseph Ng; Franca Fraternali; David Kipling; Deborah K. Dunn-Walters; Katie E. Lacy; Thomas J. Tull; Sophia Tsoka; Sophia N. Karagiannis展开收起
作者单位
1. St. John’s Institute of Dermatology, School of Basic and Medical Biosciences &, KHP Centre for Translational Medicine, Guy’s Hospital, King’s College London, London, UK; 2. Department of Informatics, Faculty of Natural, Mathematical and Engineering Sciences, King’s College London, London, UK; 3. Barts Cancer Institute, Queen Mary University of London, John Vane Science Building, London, UK; 4. School of Biosciences and Medicine, University of Surrey, Guildford, UK; 5. Department of Medical Oncology, Guy’s and St Thomas’ Hospitals, London, UK; 6. Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK; 7. Centre for Inflammation Biology and Cancer Immunology, School of Immunology & Microbial Sciences, King’s College London, London, UK; 8. St John’s Institute of Dermatology, Guy’s, and St. Thomas’ Hospitals NHS Foundation Trust, London, UK; 9. Department of Plastic Surgery, Guy’s and St. Thomas’ Hospitals NHS Foundation Trust, London, UK; 10. Randall Centre for Cell and Molecular Biophysics, School of Basic and Medical Biosciences, King’s College London, London, UK; 11. Department of Structural and Molecular Biology, Division of Biosciences and Institute of Structural and Molecular Biology, University College London, London, UK; 12. Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK展开收起
73
天
Beyond DNA damage: 3D tumor models and the integrin mechanobiology of radioresistance
作者
Nils Cordes展开收起
作者单位
1. OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 2. Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 3. German Cancer Research Center, German Cancer Consortium, Partner Site Dresden, Heidelberg, Germany; 4. National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), Heidelberg, Germany展开收起
11
天
Transcriptional evidence of neuroendocrine cell plasticity beyond histological boundaries in lung neuroendocrine neoplasms: an in-silico analysis suggesting a progression model
作者
Giuseppe Pelosi; Mauro Papotti; Riccardo Papa; Eleonora Duregon; Maria Gemelli; Sergio Harari; Angelica Sonzogni; Alice Laffi; Tommaso De Pas; Chiara Catania; Barbara Bassani; Fiorenza Lotti; Antonino Bruno; Paola Muti; Fabrizio Bianchi展开收起
作者单位
1. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; 2. Inter-Hospital Pathology Division, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) MultiMedica, Milan, Italy; 3. Department of Oncology, University of Turin, Turin, Italy; 4. Unit of Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) MultiMedica, Milan, Italy; 5. Department of Medical Sciences and Community Health, University of Milan, Milan, Italy; 6. Division of Pneumology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) MultiMedica, Milan, Italy; 7. Department of Pathology and Laboratory Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale Tumori, Milan, Italy; 8. Division of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy; 9. Laboratory of Innate Immunity, Unit of Molecular Pathology, Biochemistry, and Immunology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) MultiMedica, Milan, Italy; 10. Department of Biotechnology and Life Sciences, Laboratory of Immunology and General Pathology, University of Insubria, Varese, Italy; 11. Department of Biomedical, Surgical and Dental Health Sciences, University of Milan, Milan, Italy; 12. Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) MultiMedica, Milan, Italy; 13. Unit of Cancer Biomarkers, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
